Evidence map›Paper›PMID 22736539›Full record

ReviewJournal of biophotonics2012

Photonic crystal enhanced fluorescence for early breast cancer biomarker detection.

Brian T Cunningham, Richard C Zangar

Abstract readReview
In one paragraph

Review in Journal of biophotonics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brian T CunninghamDepartment of Electrical and Computer Engineering, Department of Bioengineering University of Illinois at Urbana-Champaign, USA. bcunning@illinois.edu.
Richard C Zangar

Funding

Photonic Crystal Surfaces for Label-Free Detection and Fluorescence AmplificationR01GM086382 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BOLLERO, GERMAN A, CUNNINGHAM, BRIAN T. · 2009 to 2012
$1.7M
NIGMS NIH HHS GM086382ANIGMS NIH HHS R01 GM086382
6 · The paper itself

Abstract

Photonic crystal surfaces offer a compelling platform for improving the sensitivity of surface-based fluorescent assays used in disease diagnostics. Through the complementary processes of photonic crystal enhanced excitation and enhanced extraction, a periodic dielectric-based nanostructured surface can simultaneously increase the electric field intensity experienced by surface-bound fluorophores and increase the collection efficiency of emitted fluorescent photons. Through the ability to inexpensively fabricate photonic crystal surfaces over substantial surface areas, they are amenable to single-use applications in biological sensing, such as disease biomarker detection in serum. In this review, we will describe the motivation for implementing high-sensitivity, multiplexed biomarker detection in the context of breast cancer diagnosis. We will summarize recent efforts to improve the detection limits of such assays though the use of photonic crystal surfaces. Reduction of detection limits is driven by low autofluorescent substrates for photonic crystal fabrication, and detection instruments that take advantage of their unique features.

Indexed as

NanostructuresPhotonsBiomarkers, TumorBreast NeoplasmsEarly Detection of CancerHumansSpectrometry, FluorescenceBiomarkers, Tumorbiomarkersfluorescence enhancementnanostructured surfacephotonic crystal

Identifiers

PMID22736539
PMCPMC3844005

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.